Scans to study how aortic stenosis worsens over time
Follows people with aortic stenosis using heart scans to learn how it progresses.
Key facts
- Who runs it
- University of Edinburgh
- Where
- Edinburgh, United KingdomSee the site
- Trial code
- Registry title
- The Scottish Aortic Stenosis LongiTudinal Imaging and biomarkeR (SALTIRE) Programme
- Status
- Recruiting
- People taking part
- 300 people, planned
- Started
- 22 May 2023
- Expected to end
- 22 May 2028
- Type of study
- Observational, 3 groups
- Treatments tested
- PET-CT
- Record updated
- 21 September 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people over 50 with aortic stenosis (a narrowed heart valve) of any severity, or an aortic valve thickening, or a tissue replacement aortic valve. It also takes healthy volunteers of similar age and sex.
- Age
- Older than 50 years.
- Sex
- Men and women can join.
- Disease stage
- Mild aortic stenosis (peak velocity 2.5-2.9 m/s), moderate (peak velocity 3.0-4.0 m/s) or severe (peak velocity >4.0 m/s; only previously recruited patients). Also aortic sclerosis: a thickened three-leaflet valve that does not block blood flow.
- Earlier treatment
- People with a bioprosthetic (tissue) aortic valve replacement can join, put in by surgery or through a catheter.
Main reasons for not taking part
- Allergy to iodinated contrast dye.
- Poor kidney function (eGFR of <30 mL/min/1.73m2).
- Pregnant or breastfeeding women.
- Known rheumatic heart disease, ochronosis or familial homozygous hypercholesterolaemia.
- Unable or unwilling to give informed consent.
The registry criteria, word for word
Show all 15 criteriaShow less
Who can take part
- Male or female aged >50 years
- Provision of informed consent prior to any study specific procedures
- Patients with bioprosthetic aortic valve replacements, including both surgically and transcatheter implanted valves
- Patients with severe aortic stenosis (peak velocity >4.0 m/s; previously recruited patients)
- Patients with moderate aortic stenosis (peak velocity 3.0-4.0 m/s; new prospectively recruited patients)
- Patients with mild aortic stenosis (peak velocity 2.5-2.9 m/s; new prospectively recruited patients)
- Patients with aortic sclerosis (tri-leaflet thickened aortic valve with no obstruction of ventricular outflow)
- Age and sex-matched healthy volunteers
Who cannot take part
- Those with an allergy to iodinated contrast
- Patients with known Rheumatic Heart Disease
- Patients with impaired renal function (eGFR of <30 mL/min/1.73m2)
- Inability or unwilling to give informed consent
- Women who are pregnant or breastfeeding
- Patients with known Ochronosis
- Patients with known Familial Homozygous Hypercholesterolaemia
Where in United Kingdom
- University of EdinburghEdinburgh, United KingdomContact: Neil CraigTaking people
About the trial
What the trial wants to find out
The goal of this observational study is to understand the processes of what causes and accelerates the disease progress in aortic stenosis and following aortic valve replacement.
Read full original descriptionShow less
Participants will undergo transthoracic echocardiography every 6 months, with annual visits for state-of-the-art scanning techniques including positron-emission tomography combined with computed tomography or magnetic resonance imaging with radiotracers designed to look at disease processes including fibrosis, calcification, inflammation and thrombosis activity.
The 3 groups in the trial
- Aortic Stenosis
Participants with Aortic Stenosis across the spectrum of disease severity
Treatment: PET-CT
- Aortic Valve Replacement
Participants who have previously undergone aortic valve replacement
Treatment: PET-CT
- Healthy Volunteers
Healthy Volunteers for the purposes of case-control analysis
Treatment: PET-CT
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- The Scottish Aortic Stenosis LongiTudinal Imaging and biomarkeR (SALTIRE) Programme
- Plain-language title
- Scans to study how aortic stenosis worsens over timeGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 21 September 2026